×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Contexte :

 

Après plusieurs décennies sans avancées majeures, de nouvelles molécules viennent redéfinir la prise en charge des cancers de l’endomètre.

 

Deux experts vous partagent leur analyse des données actuelles et des dernières recommandations à travers des cas cliniques.

 

Experts :

 

Pr Jean-Sébastien Frenel - Oncologue médical, Institut de Cancérologie de l’Ouest, Saint-Herblain

Pr Isabelle Ray-Coquard - Oncologue médical, Centre Léon Bérard, Lyon

 

Programme :

 

- Présentation des recommandations de Saint Paul de Vence 2025 dans les cancers de l’endomètre avancé ou en rechute

Jean Sébastien Frenel

 

- Cas clinique 1 : Prise en charge des tumeurs dMMR

Isabelle Ray-Coquard

 

- Cas clinique 2 : Prise en charge des tumeurs pMMR

Jean Sébastien Frenel

 

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-06-11
Last update : 2025-07-07
Jean-Sébastien Frenel
Saint-Herblain, France
Oncology

Suggestions

Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, October 16th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Monday, October 16th 2023 from 09am to 10:30am (GMT+2)
New York : Monday, October 16th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Monday, October 16th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Monday, October 16th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
Sydney : Tuesday, October 17th 2023 from 03am to 04:30am (GMT+2)
Wellington : Tuesday, October 17th 2023 from 05am to 06:30am (GMT+2)

La nouvelle classification des cancers de l’endomètre en pratique

Cycle d'enseignement - Les cancers gynécologiques

Share
Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, October 10th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, October 10th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, October 10th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, October 10th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, October 10th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, October 11th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, October 11th 2023 from 05:30am to 07am (GMT+2)

La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

Share
Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, March 14th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)

Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

Share
Scroll Up